Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy--a case report and review of the literature

Acta Oncol. 1998;37(1):107-9. doi: 10.1080/028418698423267.

Authors

M van der Heijden¹, S P Ackland, S Deveridge

Affiliation

¹ Department of Medical Oncology, Newcastle Mater Misericordiae Hospital Waratah, NSW, Australia.

PMID: 9572663
DOI: 10.1080/028418698423267

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bleomycin / administration & dosage
Bleomycin / adverse effects
Cisplatin / administration & dosage
Cisplatin / adverse effects
Epirubicin / administration & dosage
Epirubicin / adverse effects
Female
Hemolytic-Uremic Syndrome / chemically induced*
Humans
Middle Aged
Nasopharyngeal Neoplasms / drug therapy

Substances

Bleomycin
Epirubicin
Cisplatin